Items where authors include "Tanaka, Y."

Article

López‐Terrada, D.H. orcid.org/0000-0002-6584-420X, Webster, F. orcid.org/0000-0001-8706-0388, Alaggio, R. orcid.org/0000-0003-3915-3816 et al. (11 more authors) (2025) Pathology reporting of hepatoblastoma resections: recommendations from the international collaboration on cancer reporting. Histopathology. ISSN 0309-0167

Di Donato, S. orcid.org/0000-0003-1256-0761, Pauling, J.D., Ramjug, S. et al. (149 more authors) (2025) Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohort. Rheumatology. keaf290. ISSN 1462-0324

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (60 more authors) (2025) A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology. keaf053. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Rekowski, J. orcid.org/0000-0002-5207-3864, Guo, C., Solovyeva, O. et al. (35 more authors) (2025) CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials. eClinicalMedicine, 79. 102987. ISSN 2589-5370

Ursino, M., Villacampa, G., Rekowski, J. orcid.org/0000-0002-5207-3864 et al. (34 more authors) (2025) SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. eClinicalMedicine, 79. 102988. ISSN 2589-5370

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Yap, C. orcid.org/0000-0002-6715-2514, Rekowski, J. orcid.org/0000-0002-5207-3864, Ursino, M. orcid.org/0000-0002-5709-4322 et al. (32 more authors) (2023) Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT dose-finding extension (SPIRIT-DEFINE) guidance. BMJ, 383. e076386. ISSN 1759-2151

Yap, C. orcid.org/0000-0002-6715-2514, Solovyeva, O. orcid.org/0000-0001-7828-4099, de Bono, J. orcid.org/0000-0002-2034-595X et al. (32 more authors) (2023) Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT dose-finding extension (CONSORT-DEFINE) guidance. BMJ, 383. e076387. ISSN 0959-8138

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lescoat, A., Huscher, D., Schoof, N. et al. (204 more authors) (2023) Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. Rheumatology, 62 (6). pp. 2178-2188. ISSN 1462-0324

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Saxena, R., Saleheen, D., Been, L.F. et al. (45 more authors) (2013) Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India. Diabetes, 62 (5). pp. 1746-1755. ISSN 0012-1797

Proceedings Paper

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (27 more authors) (2025) OP0333 INITIAL THERAPY IN SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION IMPROVES OUTCOMES ACROSS HAEMODYNAMIC THRESHOLDS AND RISK STRATIFICATION: INSIGHTS FROM THE EUSTAR DATABASE. In: Annals of the Rheumatic Diseases. EULAR 2025: European Congress of Rheumatology, 11-14 Jun 2025, Barcelona, Spain. BMJ Publishing Group , pp. 269-271.

Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.